APA (7th ed.) Citation

Susan C. Kandarian, Rachel L. Nosacka, Andrea E. Delitto, Andrew R. Judge, Sarah M. Judge, John D. Ganey, . . . Robert W. Jackman. (2018). Tumour‐derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour‐bearing mice. Wiley.

Chicago Style (17th ed.) Citation

Susan C. Kandarian, Rachel L. Nosacka, Andrea E. Delitto, Andrew R. Judge, Sarah M. Judge, John D. Ganey, Jesse D. Moreira, and Robert W. Jackman. Tumour‐derived Leukaemia Inhibitory Factor Is a Major Driver of Cancer Cachexia and Morbidity in C26 Tumour‐bearing Mice. Wiley, 2018.

MLA (9th ed.) Citation

Susan C. Kandarian, et al. Tumour‐derived Leukaemia Inhibitory Factor Is a Major Driver of Cancer Cachexia and Morbidity in C26 Tumour‐bearing Mice. Wiley, 2018.